Literature DB >> 9330287

Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers.

B W Hollis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9330287     DOI： 10.1016/s0076-6879(97)82106-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  67 in total

1.  1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.

Authors:  Sunil K Halder; Chakradhari Sharan; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

2.  Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.

Authors:  T O Jemielita; M B Leonard; J Baker; S Sayed; B S Zemel; J Shults; R Herskovitz; M R Denburg
Journal:  Osteoporos Int       Date:  2015-09-10       Impact factor: 4.507

3.  Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.

Authors:  Kimmie Ng; Daniel J Sargent; Richard M Goldberg; Jeffrey A Meyerhardt; Erin M Green; Henry C Pitot; Bruce W Hollis; Michael N Pollak; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

4.  Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients.

Authors:  Eduard Sidelnikov; Roberd M Bostick; W Dana Flanders; Qi Long; Veronika Fedirko; Aasma Shaukat; Carrie R Daniel; Robin E Rutherford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

5.  Vitamin D deficiency and parathyroid hormone levels following renal transplantation in children.

Authors:  Shamir Tuchman; Heidi J Kalkwarf; Babette S Zemel; Justine Shults; Rachel J Wetzsteon; Debbie Foerster; C Frederic Strife; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2010-09-26       Impact factor: 3.714

6.  Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.

Authors:  Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; Joann E Manson; Nader Rifai; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

7.  Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components.

Authors:  Jennifer W Bea; Peter W Jurutka; Elizabeth A Hibler; Peter Lance; Maria E Martínez; Denise J Roe; Christine L Sardo Molmenti; Patricia A Thompson; Elizabeth T Jacobs
Journal:  Metabolism       Date:  2014-11-29       Impact factor: 8.694

8.  Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).

Authors:  Jeffrey A Meyerhardt; Kimmie Ng; Chen Yuan; Kaori Sato; Bruce W Hollis; Sui Zhang; Donna Niedzwiecki; Fang-Shu Ou; I-Wen Chang; Bert H O'Neil; Federico Innocenti; Heinz-Josef Lenz; Charles D Blanke; Richard M Goldberg; Alan P Venook; Robert J Mayer; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2019-09-23       Impact factor: 12.531

9.  Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  D Michal Freedman; Shih-Chen Chang; Roni T Falk; Mark P Purdue; Wen-Yi Huang; Catherine A McCarty; Bruce W Hollis; Barry I Graubard; Christine D Berg; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

10.  Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women.

Authors:  Angela K Green; Susan E Hankinson; Elizabeth R Bertone-Johnson; Rulla M Tamimi
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.